Literature DB >> 28286187

Hybrid Endovascular Aortic Aneurysm Repair: Preservation of Pelvic Perfusion with External to Internal Iliac Artery Bypass.

Neel A Mansukhani1, George E Havelka1, Irene B Helenowski2, Heron E Rodriguez1, Andrew W Hoel1, Mark K Eskandari3.   

Abstract

BACKGROUND: Diminished pelvic arterial flow as a result of intentional coverage/embolization of internal iliac arteries (IIA) during isolated endovascular common iliac artery aneurysm (CIAA) repair or endovascular repair of abdominal aortic aneurysms (EVAR) may result in symptomatic pelvic ischemia. Although generally well tolerated, in severe cases, pelvic ischemia may manifest as recalcitrant buttock claudication, vasculogenic impotence, or perineal, vesicle, rectal, and/or spinal cord ischemia. Branched graft technology has recently become available; however, many patients are not candidates for endovascular repair with these devices. Therefore, techniques to preserve pelvic arterial flow are needed. We reviewed our outcomes of isolated endovascular CIAA repair or EVAR in conjunction with unilateral external-internal iliac artery bypass.
METHODS: Single-center, retrospective review of 10 consecutive patients who underwent hybrid endovascular abdominal aortic aneurysm (AAA) or CIAA repair with concomitant external-internal iliac artery bypass between 2006 and 2015. Demographics, index procedural details, postoperative symptoms, hospital length of stay (LOS), follow-up imaging, and bypass patency were recorded.
RESULTS: The cohort of 10 patients was all men with a mean age of 71 years (range: 56-84). Hybrid repair consisted of contralateral IIA coil embolization followed by EVAR with external iliac artery-internal iliac artery (EIA-IIA) bypass. All EIA-IIA bypasses were performed via a standard lower quadrant retroperitoneal approach with a prosthetic bypass graft. Technical success was 100%, and there were no perioperative deaths. One patient developed transient paraplegia, 1 patient had buttock claudication on the side of his hypogastric embolization contralateral to his iliac bypass, and 1 developed postoperative impotence. 20% of patients sustained long-term complications (buttock claudication and postoperative impotence). Mean LOS was 2.8 days (range: 1-9 days). Postoperative imaging was obtained in 90% of patients, and mean follow-up was 10.8 months (range: 0.5-36 months). All bypasses remained patent.
CONCLUSIONS: Although branched graft technology continues to evolve, strategies to maintain adequate pelvic circulation are necessary to avoid the devastating complications of pelvic ischemia. We have demonstrated that a hybrid approach combining EVAR or isolated endovascular common iliac artery exclusion with a unilateral external-internal iliac bypass via a retroperitoneal approach is well tolerated with a short LOS and excellent patency rates.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28286187      PMCID: PMC5483202          DOI: 10.1016/j.avsg.2016.10.052

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  16 in total

1.  Clinical outcome of internal iliac artery occlusions during endovascular treatment of aortoiliac aneurysmal diseases.

Authors:  C W Lee; J A Kaufman; C M Fan; S C Geller; D C Brewster; R P Cambria; G M Lamuraglia; J P Gertler; W M Abbott; A C Waltman
Journal:  J Vasc Interv Radiol       Date:  2000-05       Impact factor: 3.464

2.  Parallel endografts in the treatment of distal aortic and common iliac aneurysms.

Authors:  S Lepidi; M Piazza; P Scrivere; M Menegolo; M Antonello; F Grego; P Frigatti
Journal:  Eur J Vasc Endovasc Surg       Date:  2014-05-17       Impact factor: 7.069

3.  Outcome after concomitant unilateral embolization of the internal iliac artery and contralateral external-to-internal iliac artery bypass grafting during endovascular aneurysm repair.

Authors:  Akihiro Hosaka; Masaaki Kato; Ippei Kato; Shingo Isshiki; Nobukazu Okubo
Journal:  J Vasc Surg       Date:  2011-05-31       Impact factor: 4.268

4.  Sandwich technique for aortoiliac aneurysms extending to the internal iliac artery or isolated common/internal iliac artery aneurysms: a new endovascular approach to preserve pelvic circulation.

Authors:  Armando C Lobato
Journal:  J Endovasc Ther       Date:  2011-02       Impact factor: 3.487

5.  Use of Physician-Modified Endografts to Repair Unilateral or Bilateral Aortoiliac Aneurysms.

Authors:  Madeline Nykamp; Joe Anderson; Tyler Remund; Angelo Santos; Chad Laurich; Greg Schultz; Patrick Kelly
Journal:  Ann Vasc Surg       Date:  2015-06-26       Impact factor: 1.466

6.  Beyond the aortic bifurcation: branched endovascular grafts for thoracoabdominal and aortoiliac aneurysms.

Authors:  Roy K Greenberg; Karl West; Kathryn Pfaff; James Foster; Davorin Skender; Stephan Haulon; Jamie Sereika; Leslie Geiger; Sean P Lyden; Daniel Clair; Lars Svensson; Bruce Lytle
Journal:  J Vasc Surg       Date:  2006-05       Impact factor: 4.268

7.  Internal iliac artery revascularization as an adjunct to endovascular repair of aortoiliac aneurysms.

Authors:  P L Faries; N Morrissey; J A Burks; E Gravereaux; M D Kerstein; V J Teodorescu; L H Hollier; M L Marin
Journal:  J Vasc Surg       Date:  2001-11       Impact factor: 4.268

8.  Hypogastric artery bypass to preserve pelvic circulation: improved outcome after endovascular abdominal aortic aneurysm repair.

Authors:  Frank R Arko; W Anthony Lee; Bradley B Hill; Thomas J Fogarty; Christopher K Zarins
Journal:  J Vasc Surg       Date:  2004-02       Impact factor: 4.268

9.  Relocation of the iliac artery bifurcation to facilitate endoluminal treatment of abdominal aortic aneurysms.

Authors:  J C Parodi; M Ferreira
Journal:  J Endovasc Surg       Date:  1999-11

10.  Using a surgeon-modified iliac branch device to preserve the internal iliac artery during endovascular aneurysm repair: single-center experiences and early results.

Authors:  Wei-Wei Wu; Chen Lin; Bao Liu; Chang-Wei Liu
Journal:  Chin Med J (Engl)       Date:  2015-03-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.